The Plasmodium PI(4)K inhibitor KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasites
Abstract Malaria control and elimination are threatened by the emergence and spread of resistance to artemisinin-based combination therapies (ACTs). Experimental evidence suggests that when an artemisinin (ART)-sensitive (K13 wild-type) Plasmodium falciparum strain is exposed to ART derivatives such...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/99f7a3c6162945b384400f88d2d8584f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:99f7a3c6162945b384400f88d2d8584f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:99f7a3c6162945b384400f88d2d8584f2021-12-02T15:06:20ZThe Plasmodium PI(4)K inhibitor KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasites10.1038/s41598-017-02440-62045-2322https://doaj.org/article/99f7a3c6162945b384400f88d2d8584f2017-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-02440-6https://doaj.org/toc/2045-2322Abstract Malaria control and elimination are threatened by the emergence and spread of resistance to artemisinin-based combination therapies (ACTs). Experimental evidence suggests that when an artemisinin (ART)-sensitive (K13 wild-type) Plasmodium falciparum strain is exposed to ART derivatives such as dihydroartemisinin (DHA), a small population of the early ring-stage parasites can survive drug treatment by entering cell cycle arrest or dormancy. After drug removal, these parasites can resume growth. Dormancy has been hypothesized to be an adaptive physiological mechanism that has been linked to recrudescence of parasites after monotherapy with ART and, possibly contributes to ART resistance. Here, we evaluate the in vitro drug sensitivity profile of normally-developing P. falciparum ring stages and DHA-pretreated dormant rings (DP-rings) using a panel of antimalarial drugs, including the Plasmodium phosphatidylinositol-4-OH kinase (PI4K)-specific inhibitor KDU691. We report that while KDU691 shows no activity against rings, it is highly inhibitory against DP-rings; a drug effect opposite to that of ART. Moreover, we provide evidence that KDU691 also kills DP-rings of P. falciparum ART-resistant strains expressing mutant K13.L. DembeleX. AngM. ChavchichG. M. C. BonamyJ. J. SelvaM. Yi-Xiu LimC. BodenreiderB. K. S. YeungF. NostenB. M. RussellM. D. EdsteinJ. StraimerD. A. FidockT. T. DiaganaP. BifaniNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-9 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q L. Dembele X. Ang M. Chavchich G. M. C. Bonamy J. J. Selva M. Yi-Xiu Lim C. Bodenreider B. K. S. Yeung F. Nosten B. M. Russell M. D. Edstein J. Straimer D. A. Fidock T. T. Diagana P. Bifani The Plasmodium PI(4)K inhibitor KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasites |
description |
Abstract Malaria control and elimination are threatened by the emergence and spread of resistance to artemisinin-based combination therapies (ACTs). Experimental evidence suggests that when an artemisinin (ART)-sensitive (K13 wild-type) Plasmodium falciparum strain is exposed to ART derivatives such as dihydroartemisinin (DHA), a small population of the early ring-stage parasites can survive drug treatment by entering cell cycle arrest or dormancy. After drug removal, these parasites can resume growth. Dormancy has been hypothesized to be an adaptive physiological mechanism that has been linked to recrudescence of parasites after monotherapy with ART and, possibly contributes to ART resistance. Here, we evaluate the in vitro drug sensitivity profile of normally-developing P. falciparum ring stages and DHA-pretreated dormant rings (DP-rings) using a panel of antimalarial drugs, including the Plasmodium phosphatidylinositol-4-OH kinase (PI4K)-specific inhibitor KDU691. We report that while KDU691 shows no activity against rings, it is highly inhibitory against DP-rings; a drug effect opposite to that of ART. Moreover, we provide evidence that KDU691 also kills DP-rings of P. falciparum ART-resistant strains expressing mutant K13. |
format |
article |
author |
L. Dembele X. Ang M. Chavchich G. M. C. Bonamy J. J. Selva M. Yi-Xiu Lim C. Bodenreider B. K. S. Yeung F. Nosten B. M. Russell M. D. Edstein J. Straimer D. A. Fidock T. T. Diagana P. Bifani |
author_facet |
L. Dembele X. Ang M. Chavchich G. M. C. Bonamy J. J. Selva M. Yi-Xiu Lim C. Bodenreider B. K. S. Yeung F. Nosten B. M. Russell M. D. Edstein J. Straimer D. A. Fidock T. T. Diagana P. Bifani |
author_sort |
L. Dembele |
title |
The Plasmodium PI(4)K inhibitor KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasites |
title_short |
The Plasmodium PI(4)K inhibitor KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasites |
title_full |
The Plasmodium PI(4)K inhibitor KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasites |
title_fullStr |
The Plasmodium PI(4)K inhibitor KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasites |
title_full_unstemmed |
The Plasmodium PI(4)K inhibitor KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasites |
title_sort |
plasmodium pi(4)k inhibitor kdu691 selectively inhibits dihydroartemisinin-pretreated plasmodium falciparum ring-stage parasites |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/99f7a3c6162945b384400f88d2d8584f |
work_keys_str_mv |
AT ldembele theplasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites AT xang theplasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites AT mchavchich theplasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites AT gmcbonamy theplasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites AT jjselva theplasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites AT myixiulim theplasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites AT cbodenreider theplasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites AT bksyeung theplasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites AT fnosten theplasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites AT bmrussell theplasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites AT mdedstein theplasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites AT jstraimer theplasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites AT dafidock theplasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites AT ttdiagana theplasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites AT pbifani theplasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites AT ldembele plasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites AT xang plasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites AT mchavchich plasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites AT gmcbonamy plasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites AT jjselva plasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites AT myixiulim plasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites AT cbodenreider plasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites AT bksyeung plasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites AT fnosten plasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites AT bmrussell plasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites AT mdedstein plasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites AT jstraimer plasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites AT dafidock plasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites AT ttdiagana plasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites AT pbifani plasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites |
_version_ |
1718388530679382016 |